why choose us

First received: February 24, 2023

Clinical Trial: Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diffuse Large B Cell Lymphoma

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Single-Arm, Open-Label Study Using Itacitinib as Pre-Modulation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Receiving CAR-T-Cell Therapy

Brief Summary: The purpose of the study is to assess the safety and efficacy of once daily itacitinib oral administration in participants with diffuse large B-cell lymphoma (DLBCL) who will receive CAR-T cell therapy with axicabtagene ciloleucel (axi-cel).

Read more